SCHEMBL1121808

SCHEMBL1121808

NCCc1ccc(O)c(N)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 5/20 0.69
MAPK1 P28482 3/20 0.69
DRD2 P14416 3/20 0.69
DRD1 P21728 3/20 0.69
KDM4E B2RXH2 3/20 0.69
ADRA2A P08913 3/20 0.69
SLC6A2 P23975 3/20 0.69
TDP1 Q9NUW8 3/20 0.69
MAPT P10636 2/20 0.69
DRD4 P21917 2/20 0.69
DRD5 P21918 2/20 0.69
DRD3 P35462 2/20 0.69
RECQL P46063 2/20 0.69
SLC6A3 Q01959 2/20 0.69
ALDH1A1 P00352 2/20 0.69
HTR1A P08908 2/20 0.69
APEX1 P27695 2/20 0.69
TP53 P04637 1/20 0.69
ADRB2 P07550 1/20 0.69
CYP2D6 P10635 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31484728 0.89 ALDH1A1 (0.53) TAAR1MAPK1DRD2DRD1KDM4E
SCHEMBL9008919 0.89 ALDH1A1 (0.53) TAAR1MAPK1DRD2DRD1KDM4E
SCHEMBL272900 0.84 ALOX15 (0.58) TAAR1MAPK1DRD2DRD1KDM4E
SCHEMBL11004150 0.83 ALOX15 (0.61) TAAR1MAPK1DRD2DRD1KDM4E
SCHEMBL11004234 0.83 ALOX15 (0.61) TAAR1MAPK1DRD2DRD1KDM4E
SCHEMBL18928227 0.83 ALDH1A1 (0.65) TAAR1MAPK1DRD2DRD1KDM4E
SCHEMBL10409135 0.83 TAAR1 (0.69) TAAR1MAPK1DRD2DRD1KDM4E
Dopamine SCHEMBL9166387 0.82 KDM4E (1.00) TAAR1MAPK1DRD2DRD1KDM4E
Dopamine SCHEMBL18159501 0.82 KDM4E (1.00) TAAR1MAPK1DRD2DRD1KDM4E
Dopamine SCHEMBL8505 0.82 KDM4E (1.00) TAAR1MAPK1DRD2DRD1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119591621-A Novel ecteinascidin derivatives, preparation method and application thereof, antibody drug conjugate and application thereof 泰诚思(上海)生物医药有限公司 2025-03-11 CN disclosed
WO-2023143563-A1 IGA PROTEASE TRUNCATION, FUSION PROTEIN COMPRISING IGA PROTEASE TRUNCATION, AND USE THEREOF 北京大学第一医院 2023-08-03 WO disclosed
EP-3330252-A2 ISOPRENYL COMPOUNDS AND METHODS THEREOF Signum Biosciences, Inc. (US) 2018-06-06 EP disclosed
US-9560848-B2 Method and compositions for biofouling deterrence CLEMSON UNIVERSITY (US) 2017-02-07 US disclosed
EP-2176243-B1 OPHTHALMIC LENS MATERIALS CONTAINING CHROMOPHORES THAT ABSORB BOTH UV AND SHORT WAVELENGTH VISIBLE LIGHT ALCON INC (CH) 2011-02-09 EP disclosed
EP-2176243-B1 OPHTHALMIC LENS MATERIALS CONTAINING CHROMOPHORES THAT ABSORB BOTH UV AND SHORT WAVELENGTH VISIBLE LIGHT ALCON INC (CH) 2011-02-09 EP disclosed
US-7728051-B2 Ophthalmic lens materials containing chromophores that absorb both UV and short wavelength visible light ALCON, INC. (CH) 2010-06-01 US disclosed
US-7728051-B2 Ophthalmic lens materials containing chromophores that absorb both UV and short wavelength visible light ALCON, INC. (CH) 2010-06-01 US disclosed
US-7728051-B2 Ophthalmic lens materials containing chromophores that absorb both UV and short wavelength visible light ALCON, INC. (CH) 2010-06-01 US disclosed
EP-2176243-A1 OPHTHALMIC LENS MATERIALS CONTAINING CHROMOPHORES THAT ABSORB BOTH UV AND SHORT WAVELENGTH VISIBLE LIGHT Alcon, Inc. (CH) 2010-04-21 EP disclosed
WO-2009021085-A1 OPHTHALMIC LENS MATERIALS CONTAINING CHROMOPHORES THAT ABSORB BOTH UV AND SHORT WAVELENGTH VISIBLE LIGHT ALCON, INC. (CH) 2009-02-12 WO disclosed
EP-0477501-A2 Apparatus for continuously monitoring a plurality of chemical analytes through a single optical fiber and method of making ABBOTT LABORATORIES (US) 1992-04-01 EP disclosed
US-5098659-A APPARATUS FOR CONTINUOUSLY MONITORING A PLURALITY OF CHEMICAL ANALYTES THROUGH A SINGLE OPTICAL FIBER AND METHOD OF MAKING ABBOTT LABORATORIES (US) 1992-03-24 US disclosed
US-5093355-A Hypotensive agents, cardiovascular disorders, renal failure SYNTEX (U.S.A.) INC. (US) 1992-03-03 US disclosed
EP-0457292-A2 Improved configuration fiber-optic blood gas sensor bundle and method of making ABBOTT LABORATORIES (US) 1991-11-21 EP disclosed
US-5047627-A Configuration fiber-optic blood gas sensor bundle and method of making ABBOTT LABORATORIES (US) 1991-09-10 US disclosed
EP-0404115-A1 Bis(benzylpyrrolidine)Derivatives as dopamine agonists SYNTEX (U.S.A.) INC. (US) 1990-12-27 EP disclosed
US-4958026-A HYPOTENSIVE AGENTS SCHERING AKTIENGESLLSCHAFT (DE) 1990-09-18 US disclosed
EP-0189473-A1 NEW DOPAMINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE AS MEDICINAL PRODUCTS. SCHERING AG (DE) 1986-08-06 EP disclosed
WO-1986001204-A1 NEW DOPAMINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE AS MEDICINAL PRODUCTS SCHERING AKTIENGESELLSCHAFT (DE) 1986-02-27 WO disclosed